GoAI
Get started
Tian An Medicare Limited logo

Tian An Medicare Limited

0383.HK

HKSEHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

HK$0.81

HK$0.00 · 0.00%

Aug 20, 9:15 AM HKTData delayed

0383.HK company overview

Historical prices · Market data may be delayed.

Company profile

Company website

China Medical & HealthCare Group Limited operates as an investment holding company with its core business centered on managing hospitals across the People's Republic of China, Australia, and the Philippines. The company organizes its diverse activities into six principal segments: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. Beyond its hospital operations, the group is involved in the development of independent living units and oversees the project management of health campuses dedicated to elderly care and retirement communities. These comprehensive facilities encompass elderly nursing homes, service apartments, independent living units, a shopping mall, various retail shops, and club amenities. Furthermore, the company develops and divests properties and land parcels, leases out residential and commercial office properties, provides money lending services, and delivers additional healthcare provisions. Its scope also extends to the trade of medical apparatus and related supplies, alongside engaging in the buying and selling of securities listed on international exchanges. Established in 1990, the company adopted its current name, China Medical & HealthCare Group Limited, in February 2016, having previously operated as COL Capital Limited. Its corporate headquarters are located in Wanchai, Hong Kong.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
HK
CEO
Muk Yin Kong
Listed since
Aug 1, 1991
Employees
2,716

Market position

52-week range

Current HK$0.81

Open
HK$0.81
Previous close
HK$0.81
Volume
5K
0.49× average
Average volume
10.22K
Average daily volume
Market cap
815.31M HKD
Beta
0.54
Market reference 1
50-day average
HK$0.843
-3.91% below average
200-day average
HK$0.9691
-16.41% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
96.43×
P/B (TTM)
0.49×
P/S (TTM)
0.48×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
13.43%
Operating margin
3.60%
Net margin
0.50%

Financial health

Debt / equity
0.56×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends23%11%-1%-12%Gross margin, FY2021: 12.02%Gross margin, FY2022: 11.25%Gross margin, FY2023: 18.24%Gross margin, FY2024: 19.95%Gross margin, FY2025: 16.81%Operating margin, FY2021: -3.57%Operating margin, FY2022: -4.04%Operating margin, FY2023: 5.30%Operating margin, FY2024: 5.29%Operating margin, FY2025: 1.34%Net margin, FY2021: -9.38%Net margin, FY2022: -8.59%Net margin, FY2023: 0.72%Net margin, FY2024: 1.77%Net margin, FY2025: -1.64%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 12.02%. Gross margin FY2022 11.25%. Gross margin FY2023 18.24%. Gross margin FY2024 19.95%. Gross margin FY2025 16.81%. Operating margin FY2021 -3.57%. Operating margin FY2022 -4.04%. Operating margin FY2023 5.30%. Operating margin FY2024 5.29%. Operating margin FY2025 1.34%. Net margin FY2021 -9.38%. Net margin FY2022 -8.59%. Net margin FY2023 0.72%. Net margin FY2024 1.77%. Net margin FY2025 -1.64%.

Income trends

Revenue

1.64B HKD+0.67%

Operating income

21.9M HKD-74.57%

Net income

−26.82M HKD−55.59M HKD
Income trends across reported periods1.82B HKD1.11B HKD395.35M HKD−314.84M HKDRevenue, FY2021: 1.46B HKDRevenue, FY2022: 1.44B HKDRevenue, FY2023: 1.57B HKDRevenue, FY2024: 1.63B HKDRevenue, FY2025: 1.64B HKDOperating income, FY2021: −52.22M HKDOperating income, FY2022: −58.15M HKDOperating income, FY2023: 83.21M HKDOperating income, FY2024: 86.12M HKDOperating income, FY2025: 21.9M HKDNet income, FY2021: −137.3M HKDNet income, FY2022: −123.57M HKDNet income, FY2023: 11.3M HKDNet income, FY2024: 28.77M HKDNet income, FY2025: −26.82M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.46B HKD. Revenue FY2022 1.44B HKD. Revenue FY2023 1.57B HKD. Revenue FY2024 1.63B HKD. Revenue FY2025 1.64B HKD. Operating income FY2021 −52.22M HKD. Operating income FY2022 −58.15M HKD. Operating income FY2023 83.21M HKD. Operating income FY2024 86.12M HKD. Operating income FY2025 21.9M HKD. Net income FY2021 −137.3M HKD. Net income FY2022 −123.57M HKD. Net income FY2023 11.3M HKD. Net income FY2024 28.77M HKD. Net income FY2025 −26.82M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue1.64B HKD1.63B HKD1.57B HKD1.44B HKD1.46B HKD
Cost of goods sold1.36B HKD1.3B HKD1.28B HKD1.28B HKD1.3B HKD
Gross profit275.37M HKD324.55M HKD286.22M HKD161.87M HKD175.97M HKD
Selling, general, and administrative230.95M HKD230.55M HKD236.76M HKD259.25M HKD225.43M HKD
Operating expenses253.46M HKD238.44M HKD203.01M HKD201.12M HKD197.04M HKD
Interest income21.8M HKD32.5M HKD24.47M HKD3.96M HKD1.42M HKD
Interest expense22.37M HKD29.11M HKD47.81M HKD59.02M HKD58.25M HKD
Depreciation and amortization89.91M HKD97.31M HKD92.82M HKD104.69M HKD104.53M HKD
Operating income21.9M HKD86.12M HKD83.21M HKD−58.15M HKD−52.22M HKD
Net income−26.82M HKD28.77M HKD11.3M HKD−123.57M HKD−137.3M HKD

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
-0.025
FY2025 · -193.58% year over year
Latest fiscal-year revenue
1.64B HKD
FY2025 · +0.67% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend0.05-0.04-0.13-0.21FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend1.66B1.58B1.5B1.42BFY21FY22FY23FY24FY25

0383.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$195.4

-5.05%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.50

-3.53%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$220.2

-3.42%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$48.30

-5.29%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.06

-6.11%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$98.90

-3.42%

Continue in GoAI

Research 0383.HK

research.disclaimer